Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA Warning Letters Hit Inadequate Investigations and QC Failings

This article was originally published in The Gold Sheet

Executive Summary

In recent warning letters, FDA continued to hammer manufacturers for inadequate investigation of out-of-specification results and lax oversight of manufacturing operations by quality control units.
Advertisement

Related Content

Enforcement Updates in Brief
FDA Drug GMP Warning Letters Increase 6%, Focus on Supply Chain and Sterility Assurance in FY 2011
Flu Vaccine Demand Forecast: Flat Or Up Slightly Compared With Last Year
Impax Transferring Products To Taiwan After GMP Warning Letter For U.S. Plant
FDA Continues Aggressive Enforcement as Drug GMP Warning Letters Mount
FDA Continues Aggressive Enforcement as Drug GMP Warning Letters Mount
Outsourcing Your Way Into Trouble: Pfizer Issues Recall After Indian Aurobindo Mislabels Bottles
Poor Handling of Complaints, Contractors, Contamination Draw FDA Warning Letters
February Drug Recalls
Australia's CSL Withdraws Seasonal Trivalent Flu Vaccine For Children Under 5
Advertisement
UsernamePublicRestriction

Register

PS000613

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel